Journal
JOURNAL OF HEPATOLOGY
Volume 74, Issue 3, Pages 716-733Publisher
ELSEVIER
DOI: 10.1016/j.jhep.2020.11.014
Keywords
Hepatitis C virus; HCV; Solid organ transplantation; HCV-Positive donor; Viremia; NAT
Categories
Funding
- NIH Training Program in Gastrointestinal Sciences [T32-DK007066]
Ask authors/readers for more resources
With the rise of transplanting organs from HCV antibody-positive donors to recipients with chronic HCV, the transplantation rate is expected to significantly increase and reduce waitlist mortality. However, intentionally transmitting an infectious disease to recipients poses important practical and ethical implications.
Although rates of organ donation and solid organ transplantation have been increasing over the last few decades, demand for organs still greatly exceeds supply. Several strategies have been utilised to increase organ supply, including utilisation of high-risk (e.g. HCV antibody-positive) donors. In this context, organs from HCV antibody-positive donors have been used in recipients with chronic HCV since the early 1990s. Recently, transplantation of HCV-viraemic organs into HCV-naive recipients has garnered significant interest, owing to the development of safe and highly effective direct-acting antivirals and increased experience of treating HCV in the post-transplant setting. Preliminary studies based largely in the US have shown excellent outcomes in kidney, liver, heart, and lung transplantation. This practice has the potential to significantly increase transplantation rates and decrease waitlist mortality; however, intentionally transmitting an infectious disease to recipients has important practical and ethical implications. Further, the generalisability of the US experience to other countries is limited by significant differences in HCV-viraemic donor populations. This review summarises the current data on this practice, discusses barriers to implementation, and highlights areas that warrant further study. (C) 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available